TheChek News Flow

Thrombogenics +6% : Biotech guru and Thrombogenics shareholder Marien says company should have been sold last year (in mulitple articles in weekend press).

http://trends.knack.be/economie/nieuws/finance/biotechboss-rudi-marien-thrombogenics-had-vorig-jaar-verkocht-moeten-worden/article-4000527724530.htm?nb-handled=true&utm_source=Newsletter-14/02/2014&utm_medium=Email&utm_campaign=Newsletter-RNBTRKZ